title: [Infliximab-induced hepatitis in a patient with Crohn's disease].
authors.forename: S
authors.initials: S
authors.lastname: Soto-Fernández
authors.forename: P
authors.initials: P
authors.lastname: González-Carro
authors.forename: A
authors.initials: A
authors.lastname: De Pedro-Esteban
authors.forename: M L
authors.initials: ML
authors.lastname: Legaz-Huidobro
authors.forename: F
authors.initials: F
authors.lastname: Pérez-Roldán
authors.forename: O
authors.initials: O
authors.lastname: Roncero García-Escribano
authors.forename: M
authors.initials: M
authors.lastname: Valbuena-González
authors.forename: F
authors.initials: F
authors.lastname: Ruiz-Carrillo
mesh_terms: D000208:Acute Disease; D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D003131:Combined Modality Therapy; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy* / Q000628:therapy; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069285:Infliximab; D007937:Leukapheresis; D019804:Mesalamine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D010195:Pancreatitis / Q000139:chemically induced; D011241:Prednisone / Q000627:therapeutic use; D012006:Rectovaginal Fistula / Q000188:drug therapy / Q000209:etiology
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D019804:Mesalamine; D000069285:Infliximab; D001379:Azathioprine; D011241:Prednisone; D008727:Methotrexate